This trial is testing a combination of 5 drugs to treat metastatic pancreatic cancer.
- Pancreatic Cancer
- Digestive System Tumors
- Endocrine Disorders
- Glandular Neoplasm
- Pancreatic Disease
- Gastrointestinal Disorders
- Endocrine Tumors
2 Primary · 4 Secondary · Reporting Duration: 4 years
Side Effects for
Awards & Highlights
2 Treatment Groups
1 of 2
1 of 2
86 Total Participants · 2 Treatment Groups
Primary Treatment: Gemcitabine · No Placebo Group · Phase 1 & 2
Who is running the clinical trial?
Age 18 - 76 · All Participants · 0 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
How can I qualify to be a part of this clinical research?
"This study requires that potential participants are between 18 and 76 years old, have cancer, and meet one or more of the following conditions: having at least one measurable lesion, being in good physical condition as determined by the ECOG performance status (0 or 1), using birth control while on the medication, and being a male or non-pregnant/non-lactating female over 18 years old." - Anonymous Online Contributor
What are researchers hoping to discover through this clinical trial?
"The primary objective of this medical trial, which will be conducted over the course of approximately 4 years, is to assess Progression Free Survival (PFS). Additionally, researchers will also measure secondary outcomes including toxicity levels among participants receiving GAX-CI therapy, overall survival rates, and response rates." - Anonymous Online Contributor
Is Gemcitabine a new medication?
"Gemcitabine is being studied in 2032 active clinical trials, with 604 of those studies classified as Phase 3. Many research centres are situated in Guangzhou, Guangdong; however, there are 95435 total locations conducting Gemcitabine trials worldwide." - Anonymous Online Contributor
How many individuals are allowed to enroll in this research project?
"That is right, the public information available on clinicaltrials.gov suggests that this study is actively recruiting patients. The listing was created on June 21st, 2018 and updated as recently as March 15th, 2022. This particular trial requires 86 individuals at 2 separate locations." - Anonymous Online Contributor
Are we recruiting participants who are middle-aged for this research?
"This specific trial is for individuals aged 18 to 76. 514 studies are available for people younger than this age bracket, while 5552 studies focus on patients above the age of 65." - Anonymous Online Contributor
Are patients being actively recruited for this research project?
"This is an ongoing clinical trial, as reflected by the postings on clinicaltrials.gov. Candidates are actively being sought for the trial which was first posted on 6/21/2018 and last edited on 3/15/2022." - Anonymous Online Contributor
What are the most popular conditions that Gemcitabine has been known to alleviate?
"Gemcitabine is a medication that is mostly used to treat patients with locally advanced non-small cell lung cancer, however it can also be effective for those suffering from metastatic bladder cancer, urinary bladder, and advanced testicular cancer." - Anonymous Online Contributor